BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9221629)

  • 1. [Dissent over standards in adjuvant management of colon carcinoma].
    Lorenz M; Waldeyer M; Encke A
    Zentralbl Chir; 1997; 122(4):210-21; discussion 222-3. PubMed ID: 9221629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
    Schlag PM
    Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant treatment of colonic carcinoma].
    Rochlitz CF; Herrmann R
    Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
    Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New adjuvant therapy for colon cancer: justified hope or commercial hype.
    Galanis E; Alberts SR; O'Connell MJ
    Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for colon cancer.
    Ducreux M; Boige V
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):283-98. PubMed ID: 11969239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of chemotherapy in cancers of the colon].
    Seitz JF; Rougier P
    Bull Cancer; 1994 Apr; 81(4):260-76. PubMed ID: 7535602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A; Germond C; Maroun J; Browman G; Walker-Dilks C; Wong S
    Cancer Prev Control; 1997 Dec; 1(5):379-92. PubMed ID: 9765760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemotherapy in cancers of the colon and rectum].
    Bleiberg H
    Rev Prat; 1994 Dec; 44(20):2721-6. PubMed ID: 7878362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
    Köhne-Wömpner CH; Schöffski P; Schmoll HJ
    Ann Oncol; 1994; 5 Suppl 3():97-104. PubMed ID: 8204538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
    Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for colorectal carcinoma.
    Kim R; Yamaguchi Y; Toge T
    Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
    Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
    J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.